Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer

Background: There is a lack of biomarkers for predicting the efficacy of immunotherapy in triple-negative breast cancer (TNBC). Hence, we constructed an immune risk score (IRS) model to predict the prognosis of patients with TNBC and evaluate those who are sensitive to immunotherapy. Methods: The ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaorui, Zhang, Tiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701826/
https://www.ncbi.nlm.nih.gov/pubmed/36452159
http://dx.doi.org/10.3389/fgene.2022.1067254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701826/
https://www.ncbi.nlm.nih.gov/pubmed/36452159
http://dx.doi.org/10.3389/fgene.2022.1067254

Ejemplares similares